Soft Tissue and Bone Tumors

2014 ◽  
pp. 179-179
Author(s):  
KA Moutasim ◽  
GJ Thomas
Keyword(s):  
Soft Tissue ◽  
Bone Tumors

Soft-Tissue And Bone Tumors About The Foot And Ankle

1994 ◽  
Vol 13 (4) ◽  
pp. 909-938 ◽  
Author(s):  
Arthur K. Walling ◽  
Seth I. Gasser
Keyword(s):  
Soft Tissue ◽  
Bone Tumors ◽  
Foot And Ankle

Scintigraphy with 99m Tc-Phosphonate and 67Gallium in Patients Suspected of Primary Bone Tumors

1982 ◽  
Vol 21 (04) ◽  
pp. 136-139 ◽  
Author(s):  
C.-J. Edeling
Keyword(s):  
Soft Tissue ◽  
Bone Scintigraphy ◽  
Primary Tumor ◽  
Bone Tumors ◽  
Whole Body ◽  
Skeletal Metastases ◽  
Malignant Bone Tumors ◽  
67Ga Scintigraphy ◽  
Primary Bone Tumors ◽  
Primary Bone

Whole-body scintigraphy with both 99mTc-phosphonate and 67Ga was performed on 92 patients suspected of primary bone tumors. In 46 patients with primary malignant bone tumors, scintigraphy with 99mTc-phosphonate disclosed the primary tumor in 44 cases and skeletal metastases in 11, and 67Ga scintigraphy detected the primary tumor in 43 cases, skeletal metastases in 6 cases and soft-tissue metastases in 8 cases. In 25 patients with secondary malignant bone tumors, bone scintigraphy visualized a single lesion in 10 cases and several lesions in 15 cases, and 67Ga scintigraphy detected the primary tumor in 17 cases, skeletal metastases in 17 cases and soft-tissue metastases in 9 cases. In 21 patients with benign bone disease positive uptake of 99mTc-phosphonate was recognized in 19 cases and uptake of 67Ga in 17 cases. It is concluded that bone scintigraphy should be used in patients suspected of primary bone tumors. If malignancy is suspected, 67Ga scintigraphy should be performed in addition.

scholarly journals A Review of Applications of MRI in Soft Tissue and Bone Tumors

Orthopedics ◽  
1988 ◽  
Vol 11 (3) ◽  
pp. 417-425
Author(s):  
John A Kalmar ◽  
John J Eick ◽  
Christopher R B Merritt ◽  
Stanton E Shuler ◽  
Kenneth D Miller ◽  
...  
Keyword(s):  
Soft Tissue ◽  
Bone Tumors

scholarly journals Ultrasonography of diseases of bone and muscular system

2001 ◽  
Vol 82 (4) ◽  
pp. 260-265
Author(s):  
I. V. Klyushkin ◽  
D. V. Pasynkov ◽  
V. A. Tikhonov ◽  
G. A. Nafikov ◽  
R. R. Tazeev
Keyword(s):  
Soft Tissue ◽  
Comparative Study ◽  
Bone Tumors ◽  
Ultrasound Examination ◽  
Bone Fractures ◽  
Muscular System ◽  
The Comparative Study ◽  
Optimum Application

As many as 1500 patients with various pathology of bone and muscular system were examined. The comparative study of traditional roentgenography, ultrasound examination, computer and magnetoresonance tomography was carried out to determine the optimum application in examining bone and muscular system. In many cases of the bone and muscular system diseases (bone fractures, osteomyelitis, bone tumors, soft tissue fistulas) the ultrasound examination successfully competes with other methods and in some cases, it is the method of choice.

Abstract 2139: Hippo pathway transcriptional coactivators YAP/TAZ in soft tissue and bone tumors

2019 ◽  
Author(s):  
Ilka Isfort ◽  
Sandra Elges ◽  
Magdalene Cyra ◽  
Danielle Brandes ◽  
Ruth Berthold ◽  
...  
Keyword(s):  
Soft Tissue ◽  
Bone Tumors ◽  
Hippo Pathway ◽  
Transcriptional Coactivators

scholarly journals Absence of Telomerase Activity in Malignant Bone Tumors and Soft-Tissue Sarcomas

Sarcoma ◽  
2002 ◽  
Vol 6 (1) ◽  
pp. 43-46 ◽  
Author(s):  
Nina K. Lauer ◽  
Sandra M. Maier ◽  
Martin Oberringer ◽  
Michael Schulte ◽  
Wolf Mutschler ◽  
...  
Keyword(s):  
Soft Tissue ◽  
Bone Tumors ◽  
Soft Tissue Sarcomas ◽  
Telomerase Activity ◽  
Telomeric Repeat ◽  
Malignant Bone Tumors ◽  
Trap Assay ◽  
Cell Immortalization ◽  
Amplification Assay ◽  
Subordinate Role

Purpose:Telomerase activity appears to play a crucial role in the development of many tumors. More than 80% of all malignant human tumors show an increased telomerase activity. However, conflicting results have been reported about telomerase activity in sarcomas. The aim of the study was to obtain more information about telomerase activity in sarcomas based on a large number of cases.Methods:Telomerase activity was measured in 69 different tumor samples (33 malignant bone tumors and 36 soft tissue sarcomas). Tumor samples were obtained intraoperatively and frozen immediately in liquid nitrogen. Telomerase activity was detected by the telomeric repeat amplification assay (TRAP-assay).Results:Only 7% of the samples showed telomerase activity. No correlation between staging and telomerase activity could be observed.Discussion:The fact that only five out of 69 examined tumor samples showed a telomerase activity provides experimental evidence that in sarcomas the reactivation of telomerase may play a subordinate role. Our results suggest that alternative mechanisms for cell immortalization, yet to be determined, seem to be involved in the development and/or maintenance of soft-tissue sarcomas and malignant bone tumors.

scholarly journals Treatment Effects in Pediatric Soft Tissue and Bone Tumors

2005 ◽  
Vol 123 (1) ◽  
pp. 75-90 ◽  
Author(s):  
Cheryl M. Coffin ◽  
Amy Lowichik ◽  
Holly Zhou
Keyword(s):  
Soft Tissue ◽  
Bone Tumors ◽  
Treatment Effects

scholarly journals Cytopathology of Soft Tissue and Bone Tumors

1990 ◽  
Vol 43 (2) ◽  
pp. 175-175
Author(s):  
G. Mckee
Keyword(s):  
Soft Tissue ◽  
Bone Tumors
Sign in / Sign up

Export Citation Format

Share Document